Comparative efficacy of N-Acetylcysteine (NAC) and rutin in ameliorating paclitaxel-induced hepatotoxicity in male rats
Tropical Journal of Pharmaceutical Research · 10.04.2026 · 25 (3) · 347-353
DOI: 10.4314/tjpr.v25i3.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Journal of Pharmaceutical Research, online erschienen am 10.04.2026. Verfasst von Mohammed Jasim und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Purpose
To analyze the hepatoprotective properties of N-acetylcysteine (NAC) and rutin (RU) via a rat model of paclitaxel (PAC)-induced hepatotoxicity.
Methods
Forty male Swiss albino rats were divided into four groups containing ten rats each. Paclitaxel (2 mg/kg) was administered intraperitoneally (ip) to all groups on days 1 and 7, except the control group, which received only distilled water orally. Rutin (40 mg/kg/day) was administered orally to the paclitaxel + rutin group, while 50 mg/kg/day of N-acetylcysteine was administered orally to the paclitaxel + N-acetylcysteine group. The treatments lasted for 14 days, during which liver weight, body weight change, Serum levels of Tumor necrosis factor-alpha (TNF-α) and Interleukin-10 (IL-10) were measured using enzyme-linked immunosorbent assay (ELISA), and histopathology of liver tissues was examined to evaluate tissue damage.
Results
Groups that received PAC had significantly reduced liver weight and increased serum IL-10 as well as TNF-α levels in comparison to control group (p < 0.05). The use of NAC and rutin mitigated these effects. Paclitaxel + N-acetylcysteine group showed a more significant reduction in inflammatory markers, with levels approaching values in control group (p < 0.05). Histologically, PAC caused severe hepatic damage, whereas NAC and RU preserved liver architecture, with NAC offering better protection.
Conclusion
N-acetylcysteine and rutin were equally effective in attenuating PAC-induced hepatotoxicity, with N-acetylcysteine showing superior anti-inflammatory effect and rutin better structural protection. These findings suggest that both are promising adjuvants for PAC chemotherapy.
Zitieren
APA
Jasim, M., Neamah, N., & Ghanim, W. (2026). Comparative efficacy of N-Acetylcysteine (NAC) and rutin in ameliorating paclitaxel-induced hepatotoxicity in male rats. Tropical Journal of Pharmaceutical Research, 25(3), 347-353. https://doi.org/10.4314/tjpr.v25i3.7
Vancouver
Jasim M, Neamah N, Ghanim W. Comparative efficacy of N-Acetylcysteine (NAC) and rutin in ameliorating paclitaxel-induced hepatotoxicity in male rats. Tropical Journal of Pharmaceutical Research. 2026;25(3):347-353. doi:10.4314/tjpr.v25i3.7
BibTeX
@article{Jasim2026,
author = {Jasim, Mohammed and Neamah, Nadheerah and Ghanim, Waleed},
title = {Comparative efficacy of N-Acetylcysteine (NAC) and rutin in ameliorating paclitaxel-induced hepatotoxicity in male rats},
journal = {Tropical Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {3},
pages = {347--353},
doi = {10.4314/tjpr.v25i3.7}
}
EUVIMED